Novozymes A/S (OTCMKTS:NVZMY) Posts Earnings Results, Misses Estimates By $0.11 EPS

Key Points

• Quarterly earnings missed estimates: Novozymes reported $0.51 EPS versus a $0.62 consensus (a $0.11 shortfall) and recorded a net margin of 13.96% with a return on equity of 6.37%.
• Valuation and stock snapshot: Shares opened at $62.33 with a $25.84 billion market cap, a P/E of 44.52 and PEG of 1.17, trading between a one‑year low of $49.90 and high of $75.99.
• Analyst sentiment: Rothschild & Co Redburn upgraded Novozymes to a "strong-buy," and MarketBeat shows a consensus rating of "Buy" (one Strong Buy, one Hold).

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) announced its quarterly earnings results on Tuesday. The biotechnology company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.62 by ($0.11), Zacks reports. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.37%.

Novozymes A/S Stock Performance

Shares of Novozymes A/S stock opened at $62.33 on Tuesday. The stock has a market cap of $25.84 billion, a price-to-earnings ratio of 44.52, a PEG ratio of 1.17 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.72 and a quick ratio of 0.44. Novozymes A/S has a 1 year low of $49.90 and a 1 year high of $75.99. The firm's 50-day moving average is $58.27 and its 200 day moving average is $61.14.

Analyst Upgrades and Downgrades

Separately, Rothschild & Co Redburn raised shares of Novozymes A/S to a "strong-buy" rating in a report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Novozymes A/S currently has a consensus rating of "Buy".

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company's product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.